Skip to search formSkip to main contentSkip to account menu

Aurora kinase inhibitor R763

Known as: R763 
National Institutes of Health

Related topics

Related topics

1 relation
AS703569

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
A phase I two arm trial of AS703569 (R763), an orally available aurora kinase inhibitor, in subjects with solid tumors: preliminary results
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)